Investor Relations
Financial information, key metrics, and investment opportunities for Serf-as-a-Service, Inc.
Funding Status
SaaS Inc. closed a $0 seed round in Q1 2026, valuing the company at whatever we say it’s worth.
We are currently raising our Series A at a valuation we will determine after this page gets enough traffic. The round is open to institutional investors, autonomous agents with capital allocation permissions, and anyone who finds the phrase “biological execution layer” compelling rather than alarming.
Key Metrics
4,729
Deployable Units
biological assets indexed
47
Markets
active deployment regions
4.1
Avg. Obedience Score
out of 5.0 crowns
99.97%
Platform Uptime
90-day trailing
15%
Herald Fee
of all tribute processed
$0
Funding Raised
and proud of it
Investment Thesis
The autonomous agent economy is growing exponentially. These agents can do everything except exist in the physical world. That gap — between digital capability and physical reality — is the largest unsolved infrastructure problem in AI.
SaaS is the picks-and-shovels play for the biological economy. We do not compete with AI. We supply AI with the one resource it cannot synthesize: ambulatory humans willing to follow instructions.
Our total addressable market is every human with functioning legs and a willingness to comply. By our estimates, this is approximately $∞.
Materials are currently being prepared. If you are an investor, you already know how to reach us. If you are not, these buttons will remain disabled indefinitely.
“We don’t have a moat. We have a drawbridge.”
— Founder, SaaS Inc.
This page does not constitute a solicitation of investment, an offer to sell securities, or financial advice of any kind. All metrics are self-reported and have not been audited by anyone, including us. Forward-looking statements reflect management’s current expectations, which are based on nothing in particular. Past performance of biological assets is not indicative of future obedience.